Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. VBI Vaccines's Average Total Inventories for the quarter that ended in Dec. 2023 was $8.02 Mil. VBI Vaccines's Revenue for the
three
months ended in Dec. 2023 was $0.85 Mil.
VBI Vaccines's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 9.40.
VBI Vaccines's Inventory-to-Revenue for the quarter that ended in Dec. 2023
increased
from Sep. 2023 (1.09) to Sep. 2023 (9.40)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
VBI Vaccines's Days Inventory for the
three
months ended in Dec. 2023 was 248.65.
Inventory Turnover measures how fast the company turns over its inventory within a year.
VBI Vaccines's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.37.
VBI Vaccines Inventory-to-Revenue Historical Data
The historical data trend for VBI Vaccines's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, VBI Vaccines's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VBI Vaccines Inventory-to-Revenue Distribution
For the Biotechnology industry and Healthcare sector, VBI Vaccines's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where VBI Vaccines's Inventory-to-Revenue falls into.
VBI Vaccines Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
VBI Vaccines's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
VBI Vaccines's Days Inventory for the
three
months ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VBI Vaccines Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of VBI Vaccines's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VBIV has been successfully added to your 